fda glp-1 compounding enforcement october 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of A Guide to Navigating the

BPC-157 Research BPC-157 is a promising peptide with diverse research applications in wound healing, musculoskeletal injuries, and cytoprotection

Moreover, a recent study of Medicare beneficiaries found that Black seniors were roughly one-third less likely than their white counterparts to start a GLP-1 medication, even when eligible

By indication, type 2 diabetes accounted for 87.36% revenue in 2025, but obesity and weight-management prescriptions are forecast to grow at 11.57% CAGR to 2031

Each batch undergoes analytical verification to ensure consistency in molecular composition and purity

Health Canada has issued public advisories specifically naming BPC-157, GHK-Cu, and TB-500 in seizure notices for unauthorized injectable peptide products